Cite
APA Citation
Gousis, C., Michoglou, K., Lowe, H., Kapiris, M., & Angelis, V. (2022). beyond First Line CDK4/6 Inhibitors (CDK4/6i) and Aromatase Inhibitors (AI) in Patients with Oestrogen Receptor Positive Metastatic Breast Cancer (ER+ MBC): The Guy's Cancer Centre Experience. Clinical oncology, 34(4), e178–. http://access.bl.uk/ark:/81055/vdc_100152634980.0x000032